Results 151 to 160 of about 43,858 (197)

Tofacitinib for the Management of Refractory Eosinophilic Pustular Folliculitis: A Case Report and Literature Review. [PDF]

Clin Cosmet Investig Dermatol
Zhu D, Lin Y, Li Y, Yao L.
europepmc   +1 more source

[Real-world evidence on the use of generic tofacitinib in patients with rheumatoid arthritis] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Di Giuseppe LA, Burgos MA, Posadas Martínez ML, Vargas Casalles AL, Alvarez KE, Buela G, Puga MC, Soriano Guppy ER, Rosa JE.   +8 more
europepmc   +1 more source

Updated review of Janus kinase inhibitors for the management of inflammatory bowel disease. [PDF]

World J Gastrointest Pharmacol Ther
Malakar S, Giri S, Jena A, Nath P.
europepmc   +1 more source

Atypical Prurigo Pigmentosa Following Ketogenic Diet: Successful Treatment with Doxycycline and Tofacitinib. [PDF]

Acta Derm Venereol
Zhang X, Bu Z.
europepmc   +1 more source

Multicenter experience using tofacitinib for treatment of refractory pediatric inflammatory bowel diseases in the United States. [PDF]

J Pediatr Gastroenterol Nutr
Young DD, Murphy JE, Chavannes M, Dotson JL, Tung J, Chang E, Pasternak B, Crawford E, McGreal N, Moses J, Kim SC.   +10 more
europepmc   +1 more source

Janus Kinase and Interleukin-6 Inhibitor-Induced Lipid Modulation and Its Association With Major Adverse Cardiovascular Events in Rheumatoid Arthritis: A Systematic Review of Clinical and Biomarker Evidence. [PDF]

Cureus
Patel RM, Dudley L, Morse M, Mihos CG, Kesselman MM.   +4 more
europepmc   +1 more source

A randomized controlled phase Ia clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of tofacitinib tartrate cream (HZ-J001) in healthy Chinese subjects. [PDF]

Front Pharmacol
Deng K, Huang J, Wu Q, Xie J, Yang X, Yang S, Liu L, Gong Y, Shen W, Cai L, Yang G, Guo C.   +11 more
europepmc   +1 more source

Clinical efficacy of tofacitinib in active ankylosing spondylitis and dynamic changes in gut microbiota: an exploratory descriptive four-case series with 16S rRNA sequencing analysis. [PDF]

Front Immunol
Wang L, Xie W, Li J, Chen J, Huang Y.
europepmc   +1 more source

Tofacitinib in rheumatoid arthritis: a German real-world study with focus on treatment changes, effectiveness and patient-reported outcomes (ESCALATE-RA). [PDF]

BMJ Open
Krueger K, Behrens F, Brandt-Juergens J, Detert J, Feuchtenberger M, Prothmann U, Behmer O, Hsieh MM, Jobst J, Klaus P, Meng T.   +10 more
europepmc   +1 more source

Lessons from extended induction and practical evidence for improving tofacitinib therapy in ulcerative colitis. [PDF]

World J Gastroenterol
Fouad Y, Aboelela AS.
europepmc   +1 more source